...
机译:A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Harvard Med Sch, Brigham & Womens Hosp, Div Renal Med, Boston, MA 02115 USA;
Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA;
Univ Texas MD Anderson Canc Ctr, Sect Nephrol, Houston, TX 77030 USAUniv Texas MD Anderson Canc Ctr, Dept Melanoma Oncol, Houston, TX 77030 USAUniv Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Sect Rheumatol & Clin Immunol, Houston, TXColumbia Univ, Div Nephrol, Med Ctr, New York, NY USAMayo Clin, Div Nephrol & Hypertens, Rochester, MI USAWashington Univ St Louis, Div Nephrol, St Louis, MO USAIcahn Sch Med Mt Sinai, Div Nephrol, Recanati Millar Transplant Inst, New York, NY 10029 USAUniv Washington, Div Nephrol, Seattle, WA 98195 USAVall Hebron Hosp Univ, Nephrol Dept, Barcelona, SpainUniv Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USAUniv Alabama Birmingham, Div Nephrol, Birmingham, AL USADana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAMassachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USADonald & Barbara Zucker Sch Med, Northwell Hlth Canc Inst, Div Med Oncol & Hematol, Lake SuccessDonald & Barbara Zucker Sch Med, Div Kidney Dis & Hypertens, Hempstead, NY USAKatholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Mol Immunol, Rega Inst Med ResMem Sloan Kettering Canc Ctr, Renal Serv, 1275 York Ave, New York, NY 10021 USADuke Univ, Med Ctr, Div Nephrol, Durham, NC USAUniv Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USAHarvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02115 USAHarvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02115 USAUniv S Florida, Div Nephrol & Hypertens, Tampa, FL 33620 USAH Lee Moffitt Canc Ctr & Res Inst, Renal Serv, Tampa, FL USAUniv Nebraska Med Ctr, Div Nephrol, Omaha, NE USADartmouth Hitchcock Med Ctr, Dept Hematol Oncol, Dartmouth, NS, CanadaUniv Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada;
immune checkpoint inhibitors; kidney transplant; onconephrology; rejection;